Table 3.

Regression analysis summary for predicting vaccine hesitancy.

	Everyone who is hesitant		People who plan to take BioNTech	People who plan to take Sinovac
Gender	−0.04	−0.04	−0.05	−0.02
Age	−0.02	0.00	−0.01	0.02
Education	−0.04	−0.05	−0.04	−0.18
Income	−0.03	−0.02	−0.02	0.05
Party identification	−0.04	−0.04	−0.04	0.13
Health status	−0.05	−0.05	−0.06	0.03
R2 change (%)	1.7	1.7	1.2	3.8
Knowledge of BioNTech	−0.07	−0.01	−0.04	−0.17
Knowledge of Sinovac	−0.08	−0.08	−0.02	−0.10
R2 change (%)	1.6	1.6	1.3	4.7
Perceived susceptibility to infection	0.03	0.01	0.04	−0.07
Risks from coronavirus	−0.01	−0.01	−0.07	0.17
Risks from vaccination in general	0.14*	0.05	0.07	−0.01
R2 change (%)	1.8	1.8	2.0	3.5
Risks from BioNTech		0.01	0.02	−0.02
Risks from Sinovac		0.13**	0.13*	0.11
Benefits of BioNTech		−0.24***	−0.28***	−0.23*
Benefits of Sinovac		−0.06	−0.02	0.03
R2 change (%)		6.2	7.2	5.2
Total adjusted R2	3.0	8.6	8.1	5.1

Notes. * p <.05. ^** p <.01. ^*** p <.001.